These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 9459155)

  • 81. The effects of the administration of tamoxifen, ethynyloestradiol, and prednisolone on the activities of certain enzymes of carbohydrate metabolism in primary human breast carcinomas in vivo.
    Deshpande N; Mitchell I; Maltinti M; Boi A; Di Martino L
    Br J Cancer; 1985 Aug; 52(2):241-4. PubMed ID: 3161533
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Somatuline and tamoxifen in postmenopausal breast cancer patients.
    Canobbio L; Cannata D; Miglietta L; Boccardo F
    Ann N Y Acad Sci; 1993 Nov; 698():362-6. PubMed ID: 8279776
    [No Abstract]   [Full Text] [Related]  

  • 83. Triple treatment with octreotide, galanin and serotonin is a promising therapy for colorectal cancer.
    El-Salhy M
    Curr Pharm Des; 2005; 11(16):2107-17. PubMed ID: 15974962
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Behaviour of vaginal epithelial maturation and sex hormone binding globulin in post-menopausal breast cancer patients during the first year of tamoxifen therapy.
    Bertolissi A; Cartei G; Turrin D; Cioschi B; Rizzi V
    Cytopathology; 1998 Aug; 9(4):263-70. PubMed ID: 9710696
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Prednisolone improves the response to primary endocrine treatment for advanced breast cancer.
    Rubens RD; Tinson CL; Coleman RE; Knight RK; Tong D; Winter PJ; North WR
    Br J Cancer; 1988 Nov; 58(5):626-30. PubMed ID: 3219274
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Tumour stimulation by anti-oestrogens.
    McIntosh IH; Thynne GS
    Br J Surg; 1977 Dec; 64(12):900-1. PubMed ID: 588991
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Tamoxifen treatment of metastatic breast cancer and antithrombin III levels.
    Enck RE; Rios CN
    Cancer; 1984 Jun; 53(12):2607-9. PubMed ID: 6426771
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Tamoxifen-induced hypercalcemia in breast cancer.
    Legha SS; Powell K; Buzdar AU; Blumenschein GR
    Cancer; 1981 Jun; 47(12):2803-6. PubMed ID: 7260871
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Sequential chemotherapy, beta interferon, retinoids and tamoxifen in the treatment of metastatic breast cancer. A pilot study.
    Recchia F; Rea S; Corrao G; Fingerhut A; Frati L
    Eur J Cancer; 1995 Oct; 31A(11):1887-8. PubMed ID: 8541122
    [No Abstract]   [Full Text] [Related]  

  • 90. Preventing breast cancer: is it possible?
    Ingram D
    Aust N Z J Surg; 1991 Dec; 61(12):884-91. PubMed ID: 1755767
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Body weight and vascular invasion in post-menopausal women with breast cancer.
    Badwe RA; Fentiman IS; Millis RR; Gregory WM
    Br J Cancer; 1997; 75(6):910-3. PubMed ID: 9062415
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Diabetes mellitus in breast cancer survivors: metabolic effects of endocrine therapy.
    Thomas NS; Scalzo RL; Wellberg EA
    Nat Rev Endocrinol; 2024 Jan; 20(1):16-26. PubMed ID: 37783846
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Cognitive function among women with breast cancer receiving endocrine therapy: what are the impacts?
    Fardell JE; Walker A; Chan RJ; Vardy JL
    JNCI Cancer Spectr; 2023 Mar; 7(2):. PubMed ID: 36964714
    [No Abstract]   [Full Text] [Related]  

  • 94. Severe hyperlipidemia pancreatitis induced by taking tamoxifen after breast cancer surgery-Case report.
    Zhai C; Li X; Xiao D; Chen L; Wang C; Zheng M
    Front Oncol; 2023; 13():1103637. PubMed ID: 36994195
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Towards improved endocrine therapy for advanced breast cancer.
    Rubens RD
    Ann Oncol; 1993 Nov; 4(9):712-3. PubMed ID: 8280649
    [No Abstract]   [Full Text] [Related]  

  • 96. Endocrine treatment of primary and advanced breast cancer.
    Rose C
    Int J Biol Markers; 1988; 3(1):55-6. PubMed ID: 3249045
    [No Abstract]   [Full Text] [Related]  

  • 97. Comments on Prebiopsy neo-adjuvant endocrine therapy for breast cancer to prevent post-surgery trauma-induced growth factor and immune-suppression mediated tumour progression, Oliver et al., Eur J Cancer, 32A, No. 3, pp. 396-397, 1996.
    Mokbel K
    Eur J Cancer; 1996 Dec; 32A(13):2364-6. PubMed ID: 9038624
    [No Abstract]   [Full Text] [Related]  

  • 98. [Cardiac mortality after radiotherapy, chemotherapy and endocrine therapy for breast cancer].
    Duma MN
    Strahlenther Onkol; 2020 Oct; 196(10):956-958. PubMed ID: 32561939
    [No Abstract]   [Full Text] [Related]  

  • 99.
    An J; Kwon H; Lim W; Moon BI
    J Clin Med; 2022 Apr; 11(7):. PubMed ID: 35407638
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Enhancing endocrine therapy activity via fasting cycles: biological rationale and clinical feasibility.
    Caffa I; Nencioni A
    Mol Cell Oncol; 2021; 8(1):1853492. PubMed ID: 33553607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.